PortfoliosLab logo
Innoviva, Inc. (INVA)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISIN

US45781M1018

CUSIP

45781M101

IPO Date

Oct 5, 2004

Highlights

Market Cap

$1.20B

EPS (TTM)

-$0.95

PEG Ratio

0.24

Total Revenue (TTM)

$373.30M

Gross Profit (TTM)

$322.35M

EBITDA (TTM)

$4.16M

Year Range

$15.37 - $21.28

Target Price

$55.00

Short %

19.14%

Short Ratio

10.36

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Innoviva, Inc.

Popular comparisons:
INVA vs. VOO INVA vs. QQQ
Popular comparisons:

Performance

Performance Chart


Loading data...

S&P 500

Returns By Period

Innoviva, Inc. (INVA) returned 12.33% year-to-date (YTD) and 27.05% over the past 12 months. Over the past 10 years, INVA returned 1.74% annually, underperforming the S&P 500 benchmark at 10.84%.


INVA

YTD

12.33%

1M

5.24%

6M

2.31%

1Y

27.05%

3Y*

8.03%

5Y*

6.89%

10Y*

1.74%

^GSPC (Benchmark)

YTD

0.52%

1M

6.32%

6M

-1.44%

1Y

12.25%

3Y*

12.45%

5Y*

14.20%

10Y*

10.84%

*Annualized

Monthly Returns

The table below presents the monthly returns of INVA, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
20257.44%-3.86%1.17%3.09%4.28%12.33%
20241.00%-5.68%-0.26%-0.85%4.50%3.86%14.88%2.87%-0.36%1.29%-2.91%-8.64%8.17%
2023-4.53%-4.58%-6.79%4.27%15.00%-5.63%6.44%-5.90%1.88%-4.46%11.60%15.81%21.06%
2022-7.07%19.84%0.73%-11.83%-11.08%-2.70%-2.85%-8.23%-11.78%16.80%-3.17%0.91%-23.19%
2021-3.07%-4.83%4.55%-4.18%17.47%-0.30%5.74%7.62%9.50%4.43%-4.18%3.17%39.23%
2020-2.47%-2.46%-12.69%20.58%-1.48%0.07%-3.08%-13.58%-10.76%3.44%-3.24%18.45%-12.50%
2019-2.01%-8.19%-10.64%0.00%-2.57%6.51%-18.41%-2.44%-9.06%10.25%16.01%5.04%-18.85%
20182.82%6.31%7.48%-13.02%2.00%-6.69%2.54%2.61%4.96%-8.40%30.80%-4.44%22.97%
2017-0.93%8.96%19.74%-14.75%3.65%4.75%7.19%2.33%0.57%-13.31%7.19%8.16%32.62%
2016-4.93%16.97%7.42%-1.99%-8.59%-6.65%22.22%-13.83%-0.90%-6.28%0.39%3.48%1.52%
2015-20.35%60.25%-11.87%3.37%4.00%8.44%-15.22%-9.20%-47.41%22.28%5.35%13.95%-22.07%
20143.28%0.49%-16.38%-12.99%6.43%28.99%-27.13%9.79%-27.46%-6.26%-3.84%-6.48%-49.29%
Go deeper with the Portfolio Analysis tool — backtest performance, assess risk, compare to benchmarks, and more

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

With an overall rank of 81, INVA is among the top 19% of stocks on our website when it comes to balancing risk and reward. Below is a breakdown of how it compares using common performance measures.


The Risk-Adjusted Performance Rank of INVA is 8181
Overall Rank
The Sharpe Ratio Rank of INVA is 9191
Sharpe Ratio Rank
The Sortino Ratio Rank of INVA is 8484
Sortino Ratio Rank
The Omega Ratio Rank of INVA is 8181
Omega Ratio Rank
The Calmar Ratio Rank of INVA is 7171
Calmar Ratio Rank
The Martin Ratio Rank of INVA is 7878
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for Innoviva, Inc. (INVA) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


The Sharpe ratio helps investors understand how much return they're getting for the level of risk taken. A higher Sharpe ratio indicates better risk-adjusted performance, meaning more reward for each unit of risk.

Innoviva, Inc. Sharpe ratios as of May 30, 2025 (values are recalculated daily):

  • 1-Year: 1.57
  • 5-Year: 0.23
  • 10-Year: 0.05
  • All Time: 0.04

These values reflect how efficiently the investment has delivered returns relative to its volatility over different time periods. All figures are annualized and based on daily total returns (including price changes and dividends).

The chart below shows the rolling Sharpe ratio of Innoviva, Inc. compared to the selected benchmark. This view highlights how the investment's risk-adjusted performance has changed over time.


Loading data...

Go to the full Sharpe Ratio tool to analyze any stock or portfolio. Customize time frames, set your own risk-free rate, and more

Dividends

Dividend History

Innoviva, Inc. provided a 0.00% dividend yield over the last twelve months, with an annual payout of $0.00 per share.


0.00%2.00%4.00%6.00%8.00%$0.00$0.20$0.40$0.60$0.8020142015201620172018201920202021202220232024
Dividends
Dividend Yield
PeriodTTM20242023202220212020201920182017201620152014
Dividend$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.75$0.50

Dividend yield

0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%7.12%3.53%

Monthly Dividends

The table displays the monthly dividend distributions for Innoviva, Inc.. The dividends shown in the table have been adjusted to account for any splits that may have occurred.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2025$0.00$0.00$0.00$0.00$0.00$0.00
2024$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
2023$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
2022$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
2021$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
2020$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
2019$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
2018$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
2017$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
2016$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
2015$0.00$0.00$0.25$0.00$0.00$0.25$0.00$0.00$0.25$0.00$0.00$0.00$0.75
2014$0.25$0.00$0.00$0.25$0.00$0.50

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


Loading data...

Worst Drawdowns

The table below displays the maximum drawdowns of the Innoviva, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Innoviva, Inc. was 84.32%, occurring on Nov 21, 2008. Recovery took 1123 trading sessions.

The current Innoviva, Inc. drawdown is 38.90%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-84.32%May 23, 2007381Nov 21, 20081123May 13, 20131504
-78.74%Jul 12, 2013559Sep 29, 2015
-26.22%Apr 6, 200652Jun 20, 200685Oct 19, 2006137
-21.77%Feb 9, 200737Apr 3, 200734May 22, 200771
-20.78%May 15, 201315Jun 5, 201325Jul 11, 201340
Go to the full Drawdowns tool for more analysis options, including inflation-adjusted drawdowns, and more

Volatility

Volatility Chart

The chart below shows the rolling one-month volatility.


Loading data...

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Innoviva, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.


Annual
Quarterly

0.0

Earnings Per Share

The chart presents the Earnings Per Share (EPS) performance of Innoviva, Inc., comparing actual results with analytics estimates. In the past quarter, the company did not meet analyst expectations for EPS, resulting in a surprise of -36.6%.


-1.000.001.002.003.0020212022202320242025
-0.74
0.41
Actual
Estimate

Valuation

The Valuation section provides an overview of how Innoviva, Inc. is priced in the market compared to other companies in the Biotechnology industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.


PEG Ratio

The chart shows the Price/Earnings to Growth (PEG) ratio for INVA compared to other companies in the Biotechnology industry. INVA currently has a PEG ratio of 0.2. This PEG ratio is low compared to industry peers, which could indicate the stock is undervalued relative to its expected growth.

PS Ratio

This chart shows the Price-to-Sales (P/S) ratio for INVA relative to other companies in the Biotechnology industry. Currently, INVA has a P/S ratio of 3.3. This P/S ratio falls within the average range for the industry, suggesting the stock is fairly valued based on its revenue.

PB Ratio

The chart illustrates the Price-to-Book (P/B) ratio for INVA in comparison with other companies in the Biotechnology industry. Currently, INVA has a P/B value of 1.9. This P/B ratio is in line with the industry average, suggesting the stock is valued fairly in relation to its book value.

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items